Preview

Meditsinskiy sovet = Medical Council

Advanced search
Fullscreen

For citations:


Goryainova AY, Stukan AI, Murashko RA, Sharov SV, Lymar EV. Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative breast cancer. Meditsinskiy sovet = Medical Council. 2022;(9):40-48. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-9-40-48

Views PDF (Rus): 279


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)